Inovio Pharmaceuticals Inc (INO)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Acquisition | 6,027 | |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Acquisition | 6,027 | |
| May 20, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Disposal | 8,700 | 0 |
| May 20, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Disposal | 8,700 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Disposal | 9,450 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Disposal | 9,450 | 0 |
| May 20, 2026 | SHEPARD, JAY | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | BENITO, SIMON X | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | BENITO, SIMON X | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock Option | Acquisition | 46,876 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock Option | Acquisition | 46,876 | 0 |
| May 20, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Acquisition | 32,480 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Disposal | 2,693 | 1.23 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Disposal | 2,693 | 1.23 |
| May 20, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Acquisition | 32,480 | 0 |
| May 20, 2026 | WEINER, DAVID B. | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | WEINER, DAVID B. | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | MILLER, ANN CALBY | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | YARNO, WENDY L | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Disposal | 28,296 | 0 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Disposal | 28,296 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Acquisition | 37,684 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Acquisition | 37,684 | 0 |
| May 20, 2026 | DANSEY, ROGER D | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | DANSEY, ROGER D | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock Option | Acquisition | 34,160 | 0 |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock Option | Acquisition | 34,160 | 0 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Acquisition | 100,240 | 0 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Acquisition | 100,240 | 0 |
| May 20, 2026 | ZOTH, LOTA S. | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | ZOTH, LOTA S. | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Disposal | 6,027 | 0 |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Disposal | 6,027 | 0 |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Acquisition | 9,450 | |
| May 20, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Acquisition | 9,450 | |
| May 20, 2026 | BENITO, SIMON X | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | BENITO, SIMON X | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | KIES, PETER | CFO | Common Stock Option | Acquisition | 39,760 | 0 |
| May 20, 2026 | KIES, PETER | CFO | Common Stock Option | Acquisition | 39,760 | 0 |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Acquisition | 27,440 | 0 |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Acquisition | 27,440 | 0 |
| May 20, 2026 | WEINER, DAVID B. | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | WEINER, DAVID B. | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | KIES, PETER | CFO | Common Stock | Disposal | 4,688 | 1.23 |
| May 20, 2026 | KIES, PETER | CFO | Common Stock | Disposal | 4,688 | 1.23 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Acquisition | 28,296 | |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Acquisition | 28,296 | |
| May 20, 2026 | DANSEY, ROGER D | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | MILLER, ANN CALBY | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | MILLER, ANN CALBY | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | YARNO, WENDY L | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Disposal | 12,306 | 1.23 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Disposal | 12,306 | 1.23 |
| May 20, 2026 | ZOTH, LOTA S. | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | ZOTH, LOTA S. | Director | Restricted Stock Unit | Acquisition | 34,200 | 0 |
| May 20, 2026 | SHEPARD, JAY | Director | Common Stock Options | Acquisition | 41,800 | 0 |
| May 20, 2026 | KIES, PETER | CFO | Common Stock | Acquisition | 8,700 | |
| May 20, 2026 | KIES, PETER | CFO | Common Stock | Acquisition | 8,700 | |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Disposal | 2,163 | 1.23 |
| May 20, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Disposal | 2,163 | 1.23 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock Option | Acquisition | 123,760 | 0 |
| May 20, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock Option | Acquisition | 123,760 | 0 |
| May 15, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Disposal | 1,712 | 1.3 |
| May 15, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Disposal | 2,385 | 0 |
| May 15, 2026 | KIES, PETER | CFO | Common Stock | Disposal | 2,571 | 1.3 |
| May 15, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Acquisition | 17,744 | |
| May 15, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Disposal | 4,771 | 0 |
| May 15, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Disposal | 4,771 | 0 |
| May 15, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Acquisition | 2,385 | |
| May 15, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Disposal | 7,717 | 1.3 |
| May 15, 2026 | KIES, PETER | CFO | Common Stock | Acquisition | 4,771 | |
| May 15, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Disposal | 680 | 1.3 |
| May 15, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Acquisition | 4,771 | |
| May 15, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Disposal | 17,744 | 0 |
| Mar 31, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Disposal | 4,292 | 0 |
| Mar 31, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Disposal | 1,223 | 1.74 |
| Mar 31, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Acquisition | 4,292 | |
| Mar 4, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock Option | Acquisition | 36,832 | 0 |
| Mar 4, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Acquisition | 21,560 | 0 |
| Mar 4, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock Option | Acquisition | 26,840 | 0 |
| Mar 4, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Acquisition | 78,760 | 0 |
| Mar 4, 2026 | KIES, PETER | CFO | Common Stock Option | Acquisition | 31,240 | 0 |
| Mar 4, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Acquisition | 29,608 | 0 |
| Mar 4, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Acquisition | 25,520 | 0 |
| Mar 4, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock Option | Acquisition | 97,240 | 0 |
| Feb 26, 2026 | WEINER, DAVID B. | Director | Common Stock | Acquisition | 972 | |
| Feb 26, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Acquisition | 5,010 | |
| Feb 26, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Disposal | 13,657 | 1.79 |
| Feb 26, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Disposal | 18,632 | 0 |
| Feb 26, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Disposal | 11,550 | 0 |
| Feb 26, 2026 | KIES, PETER | CFO | Common Stock | Disposal | 2,965 | 1.79 |
| Feb 26, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Acquisition | 7,366 | |
| Feb 26, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Disposal | 5,010 | 0 |
| Feb 26, 2026 | KIES, PETER | CFO | Common Stock | Acquisition | 5,010 | |
| Feb 26, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Disposal | 5,010 | 0 |
| Feb 26, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Disposal | 2,064 | 1.79 |
| Feb 26, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Acquisition | 28,401 | |
| Feb 26, 2026 | WEINER, DAVID B. | Director | Restricted Stock Unit | Disposal | 972 | 0 |
| Feb 26, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Restricted Stock Unit | Disposal | 5,010 | 0 |
| Feb 26, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Restricted Stock Unit | Disposal | 28,401 | 0 |
| Feb 26, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Disposal | 8,057 | 1.79 |
| Feb 26, 2026 | KIES, PETER | CFO | Restricted Stock Unit | Disposal | 10,634 | 0 |
| Feb 26, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Acquisition | 5,010 | |
| Feb 26, 2026 | SHEA, JACQUELINE ELIZABETH | Director, Chief Executive Officer | Common Stock | Acquisition | 18,632 | |
| Feb 26, 2026 | KIES, PETER | CFO | Common Stock | Disposal | 6,294 | 1.79 |
| Feb 26, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Restricted Stock Unit | Disposal | 7,366 | 0 |
| Feb 26, 2026 | KIES, PETER | CFO | Common Stock | Acquisition | 10,634 | |
| Feb 26, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Acquisition | 11,550 | |
| Feb 26, 2026 | SUMNER, MICHAEL JOHN | Chief Medical Officer | Common Stock | Disposal | 3,903 | 1.79 |
| Feb 26, 2026 | HUMEAU, LAURENT | Chief Scientific Officer | Common Stock | Disposal | 3,034 | 1.79 |